Alzheimer’s disease is one of the most feared illnesses of old age. It slowly damages and kills brain cells, causing a person to lose memory, thinking skills, and the ability to manage daily life.
In the early stages, people may forget recent events or have trouble finding the right words. As the disease gets worse, they may become confused, lose their independence, and eventually fail to recognize family members and close friends. In the final stages, many people need full-time care.
Around the world, millions of families are living with the emotional and financial burden of this devastating disease, and the number of cases is expected to rise as populations age.
Scientists have spent many years trying to understand exactly what causes Alzheimer’s disease and how it can be treated. Unfortunately, current medicines can only slow the symptoms slightly and cannot stop or reverse the disease. This is why researchers continue to search for new and better ways to protect the brain.
One of the main features of Alzheimer’s disease is the buildup of a protein called amyloid beta. In healthy brains, this protein is normally cleared away. In people with Alzheimer’s disease, however, amyloid beta can stick together and form clumps known as plaques.
These plaques are believed to damage nerve cells and interfere with communication between different parts of the brain.
In recent years, scientists have developed new drugs that use antibodies to remove amyloid beta from the brain. Although these medicines are an important scientific advance, they also have limitations.
They can be extremely expensive, are not easily available to everyone, and may sometimes cause serious side effects. As a result, researchers are still searching for treatments that are safer, simpler, and more affordable.
A new study published in the journal Neurochemistry International has provided an interesting and hopeful new idea. Researchers from Kindai University in Japan and their partner institutions found that oral arginine, a naturally occurring amino acid, may help reduce the harmful buildup of amyloid beta in the brain.
Arginine is already familiar to scientists and doctors. It is found naturally in many foods and is sold worldwide as a dietary supplement.
The body uses arginine for several important functions, including improving blood flow, supporting wound healing, and helping the immune system work properly. Because it already has a long history of use in humans, it may have advantages over completely new drugs.
The study was led by graduate student Kanako Fujii and Professor Yoshitaka Nagai from the Department of Neurology at Kindai University, together with Associate Professor Toshihide Takeuchi from the university’s Life Science Research Institute. Their goal was to determine whether arginine could reduce the formation and harmful effects of amyloid beta.
The researchers first carried out laboratory experiments using solutions that contained amyloid beta. They discovered that when arginine was added, the protein became much slower to form clumps.
They also found that higher amounts of arginine produced stronger effects. These results suggested that arginine directly interferes with the process that causes amyloid beta to stick together.
The team then tested arginine in living models of Alzheimer’s disease. One model involved fruit flies that had been genetically altered to produce a highly toxic form of amyloid beta.
The other involved mice carrying three genetic changes linked to Alzheimer’s disease in humans. These models are widely used because they develop brain changes that resemble many aspects of the human disease.
The results were encouraging. In both the fruit flies and the mice, oral arginine treatment reduced the buildup of amyloid in the brain. In the mice, the amount of amyloid plaques was significantly lower. The treatment also reduced levels of an especially harmful form of the protein called insoluble Aβ42.
The researchers also found evidence that arginine could help protect brain function. The treated mice performed better on tests that measure learning and memory.
In addition, the scientists observed lower levels of inflammatory signals in the brains of the treated animals. Brain inflammation is another important feature of Alzheimer’s disease because it can worsen nerve cell damage and speed up the progression of the illness.
Professor Nagai explained that one of the most exciting aspects of this discovery is that arginine is already known to be relatively safe and inexpensive. Since it is approved for medical use in Japan and can enter the brain, it may be possible to move more quickly toward clinical testing than would be possible with an entirely new drug.
This type of work is called drug repositioning, which means finding new uses for substances that are already known to be safe. Drug repositioning can save considerable time and money and may allow promising treatments to reach patients more quickly.
The researchers emphasized that the doses used in their study do not match commercial supplements and that people should not assume that taking arginine supplements will prevent or treat Alzheimer’s disease.
Much more work still needs to be done. Further studies and carefully designed human clinical trials will be necessary to determine whether arginine can truly help people with Alzheimer’s disease and to identify the safest and most effective treatment approach.
Even so, the findings offer an important reason for hope. The study shows that a simple and naturally occurring compound can reduce harmful changes in the brain and improve function in animal models of Alzheimer’s disease.
If future research confirms these benefits in people, treatments for Alzheimer’s disease may one day include not only complex and expensive medicines but also more affordable therapies that are accessible to many more patients around the world.
If you care about Alzheimer’s disease, please read studies about vitamin D deficiency linked to Alzheimer’s and dementia, and strawberries can be good defence against Alzheimer’s.
For more health information, please see recent studies about foods that reduce Alzheimer’s risk, and oral cannabis extract may help reduce Alzheimer’s symptoms.
Copyright © 2026 Knowridge Science Report. All rights reserved.
